Citation:Deng Y, Wang L, Tan S, Kim GP, Dou R, Chen D, et al 2015

From Cancer Guidelines Wiki

Citation


Deng Y, Wang L, Tan S, Kim GP, Dou R, Chen D, et al. KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer. Mol Oncol 2015 Aug;9(7):1341-7 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25864038.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Optimal molecular profilingBen Lee-Batescompleted
Optimal molecular profilingVictoria Freemancompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Optimal molecular profiling